首页 › 基金 › Lion Point Capital, LP › ARQT

Lion Point Capital, LP 对 ARQT 的持仓历史

ARCUTIS BIOTHERAPEUTICS INC · 医疗保健

Lion Point Capital, LP 在 Q3 2026 的 13F 申报中披露持有 ARQT(ARCUTIS BIOTHERAPEUTICS INC)5,250 股,市值约 US$139K,约占其申报组合的 0.80%,在其申报持仓中市值排名第 31 位。 Lion Point Capital, LP 最近 9 个申报季度中有 9 个季度披露了 ARQT 持仓,最早可追溯至 Q3 2024。

最新持仓 (Q3 2026)5.25K 股
申报持仓市值$138.76K
组合权重0.80%
首次申报Q3 2024
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Lion Point Capital, LP 对 ARQT 的持仓演变

Lion Point Capital, LP 于 Q3 2024 首次披露 ARQT 持仓:35,100 股(约 US$326K)。 该持仓在 Q1 2025 达到峰值 46,300 股,市值约 US$724K。 在 9 次申报中,Lion Point Capital, LP 1 次增持、2 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 5,250 股、市值约 US$139K。 持仓曾出现大幅变动:Q4 2024 增持约 32% (随后一个季度股价上涨 12%)、Q4 2025 减持约 85% (随后一个季度股价下跌 19%)。

逐季持仓明细

季度股数金额变化
Q3 2024 35.10K $326.43K 新进
Q4 2024 46.30K $644.96K 增持
Q1 2025 46.30K $724.13K 持有
Q2 2025 46.30K $649.13K 持有
Q3 2025 35.30K $665.40K 减持
Q4 2025 5.25K $152.46K 减持
Q1 2026 5.25K $123.69K 持有
Q2 2026 5.25K $137.66K 持有
Q3 2026 5.25K $138.76K 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ARQT 与 13F 数据

ARQT(ARCUTIS BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 ARQT,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$324.3M), Frazier Life Sciences Management, L.P. (US$261.0M), Rubric Capital Management LP (US$222.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ARQT 的基金

查看 ARQT 的全部基金持有人 →

常见问题

How long has Lion Point Capital, LP held ARQT?

Lion Point Capital, LP has disclosed ARQT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Lion Point Capital, LP's current position in ARQT?

As of Q3 2026, Lion Point Capital, LP holds 5.25K shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), valued at $138.76K, representing 0.80% of its reported portfolio and ranking #31.

Has Lion Point Capital, LP been buying or selling ARQT?

In the latest 13F filing (Q3 2026), Lion Point Capital, LP held unchanged its position in ARQT. The position peaked in Q1 2025 at 46.30K shares.

Which other funds hold ARQT?

Other major institutional holders of ARQT include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.